Analog company starts with technology.

Chapter 240 Can't Listen
Fast forward to September.

At this moment, it has been a month and a half since the release of Mechanical Dawn.

Coupled with the sales performance of the virtual theater, the national box office has reached 80 billion, ranking first in the movie box office rankings.

If calculated by the global box office results, it has broken through the astonishing [-] billion mark.

This is a huge achievement that has never been seen in the history of domestic films, especially for the sci-fi theme that is least favored by the outside world.

It can be said that it has completely achieved a win-win situation for all parties.

It plays a vital role in promoting the diversified development of domestic films.

Although this point of box office Xingyuan Technology is not very eye-catching, Niu Geng is still very satisfied that it can let those overseas users really see the powerful functions of companion robots and regret what they did at the beginning.

After all, as a technology company, the first time it set foot in the film and television industry, it reached the ceiling level, which is beyond the imagination of others.

However, after Mechanical Dawn achieved such great results, Niu Geng did not immediately plan to invest in the next film.

The main reason why Xingyuan Technology invested in the filming of Mechanical Dawn was Guo Yifan.

At the beginning, he came to him and wanted to use the companion robot as a prop for filming. It happened that Niu Geng wanted to justify the reputation of the companion robot overseas, which led to this matter.

There is no goal of reaching the box office.

Besides, the current focus of Xingyuan Technology is on the research and development of intelligent robots and anti-cancer drugs, and it has no idea of ​​entering the film and television industry for the time being.

Of course, it is impossible to be like some film and television companies, who can't wait to make many movies a year.

more importantly.

Without a suitable script, no matter how large the investment is, it is very likely that the final film will be a bad movie.

Niu Geng will not self-destruct the good impression Xingyuan Technology has left in the hearts of users over the years.

What made Niu Niugeng more gratified was that Guo Yifan had the same opinion as him.

He didn't pick the wrong director at the beginning.

And for more than a month, Jingzhou Xingyuan Cancer Prevention and Treatment Hospital has received many cancer patients transferred from all over the country, and the hospital beds are already full.

of course.

These patients transferred from other hospitals did not think that Xingyuan Cancer Hospital could treat their cancer well.

Mainly to get a spot.

A clinical trial quota.

Yes.

In terms of Xingyuan Bio, Gu Wenyu led the project team to successfully develop a universal anticancer drug with the assistance of Xingling.

Now it has entered the clinical testing stage, and it won't take long to get the batch number and successfully launch it.

Most of the patients transferred to Jingzhou Xingyuan Cancer Prevention and Treatment Hospital are already in the advanced stage and suffering from pain. For them, there is no time to wait for the anticancer drug developed by Xingyuan Biotech to come online.

The only way is to participate in clinical trials.

Perhaps there is a relatively large risk in it. If the medicine goes wrong, it may cause irreversible damage to their bodies.

But this is also the last gamble on life.

With the attitude of putting yourself to death and then reviving, even if there is a glimmer of life, it is much better than sitting still and waiting for death.

It's just that Xingyuan Biotech has just been established, and has never had any experience in drug research and development before. It is inevitable that patients and their families will feel uncertain about such a difficult project of anticancer drugs.

That is to say, the strong medical resources of Jingzhou Cancer Prevention and Treatment Hospital and various advanced medical equipment in the hospital gave them the confidence to participate in clinical trials.

But when Niu Geng was waiting for the anti-cancer drug to end its clinical trials and start mass production and put it on the market, the island country released a news that he didn't expect.

……

……

Saturday, April 9.

Cabinet Minister Asada Jiro personally held a press conference and announced an exciting news for the public.

Dongjing Pharmaceutical Research Institute successfully developed anti-cancer drugs.

It has therapeutic effects on common cancer diseases.

And it will be distributed to major hospitals in the near future to provide free treatment for patients with cancer induced by nuclear wastewater pollution.

As soon as this news comes out.

Immediately aroused huge repercussions in the society.

In addition to the hype of local media organizations, even many Western media have also reported on this matter, as if they had already said hello.

Since the pollution of nuclear wastewater caused changes in marine life, the island country has completely banned marine fishing and farming, which has greatly affected the economy.

Coupled with the continuous increase in the number of cancer patients, public discussion has almost reached a very high level, which may cause confusion at any time.

Once this happens, it is bound to make the situation worse.

The emergence of anticancer drugs is like a shot in the arm, effectively stabilizing the anxiety of the people.

In particular, the drug is free for most cancer patients.

Let everyone regain their confidence.

It's just that Jiro Asada really has such a strong ability to deal with risks?
-

Go back in time to a few days ago.

In his office, Asada Jiro suddenly met Iku Nakamura, the main person in charge of the anticancer drug research and development project.

"Professor Nakamura, there is no other purpose in asking you to come here today, I just want to know about the progress of Shenze's research and development."

Facing Iku Nakamura in front of him, Asada Jiro didn't beat around the bush, and directly expressed his appeal.

As for Shenze in his mouth, it is the name of an anticancer drug that is still in the research and development stage.

Meeting on this occasion, Iku Nakamura seemed quite excited, and replied directly after hearing the sound: "Report to Mr. Asada, we have made a major breakthrough in the Shenze project. Not surprisingly, it will treat several common types of cancer. Have a very good therapeutic effect."

"Currently, Shenze is in the clinical trial stage, and my team and I will speed up the research and development progress, and strive to make it go online as soon as possible for the treatment of cancer patients in China."

There was a sense of pride in his tone, and he was obviously very confident in his drug.

Asada Jiro nodded, and then asked: "Well, I don't know how long it will take?"

"Not sure."

Nakamura Yu thought for a while before giving such an answer.

It’s not that he was deliberately perfunctory. No one can guarantee that the results of the main clinical trials will be smooth. Even if there is any situation beyond the control of the process, the drug needs to be re-researched and analyzed to avoid the danger of this existence. .

In this way, the time consumed in the process is naturally impossible to estimate.

Because in any case, drugs are related to the safety of human life, let alone this kind of anticancer drug for treating major diseases, absolutely no problems are allowed.

Otherwise, it is very likely to cause major accidents if it is put on the market rashly.

This is why there is such a link as clinical trials in the drug development process.

However, Iku Nakamura did not notice that after he said this answer, Jiro Asada, who was sitting in the office, frowned slightly.

Doesn't seem too happy with this answer.

In the spacious office, after several seconds of silence, Asada Jiro raised his gaze again.

With a full face, he said solemnly: "Professor Nakamura, I think you should be very clear about the current situation. Shenze must be released as soon as possible."

Before the island side was unable to reach a cooperation intention with Xingyuan Technology on the incident of nuclear wastewater pollution, they could not purchase new bacterial solutions. In order to solve this problem, Asada Jiro had to change the plan and choose to develop anti-cancer drugs.

fundamentally dealt with.

But after such a long period of time, the anti-cancer drug has not been launched for a long time, which puts more and more pressure on him, and the situation seems to be about to collapse.

Under such circumstances, Asada Jiro couldn't wait for a day, and wanted to use Shen Ze's influence to stabilize the situation as soon as possible.

That's why he suddenly called Nakamura Yu to his office at this time.

But Iku Nakamura's answer was not the answer he wanted to hear. For the sake of the overall situation, I am afraid there is only one way to choose under certain circumstances.

That is to take risks.

And Nakamura Yu obviously didn't fully understand what Asada Jiro meant, and still responded according to his own words: "Of course I understand that the current situation is very bad, but please rest assured, Chief Asada, our team will definitely let Shenze go online in the shortest possible time. "

At this time, Asada Jiro also clearly understood that if the two of them continued to talk in this way of communication, there would be no results in the end.

So I simply chose to be more straightforward, and then continued: "Professor Nakamura, you have to understand that we can wait for this time, but can those patients who should eat mutated seafood to induce cancer?"

The moment he heard these words, Nakamura Yuki was stunned for a moment, as if he was trying to understand something, and there was a sense of instant realization.

After a pause for a few seconds, he asked in a rather apprehensive mood, "Sir Asada, what do you mean?"

"It's simple."

Asada Jiro said categorically: "Skip the clinical trial stage and directly put Shenze on the market."

what?
No clinical trials?

It was obviously the first time for Iku Nakamura to hear such remarks, and he felt that his worldview collapsed. He never expected Asada Jiro to make such a frightening decision.

So much so that he froze in place, and he didn't come back to his senses for a long time.

It is necessary to know that there is no way to determine the safety of a drug without clinical trials. In a sense, its essence is no different from poison.

If something goes wrong after it is put on the market, it is likely to cause premature death of all cancer patients.

At that time, it will inevitably cause a big shock in the entire medical field.

And there is no way to hide this kind of accident. As a medical professor, Nakamura Yu's knowledge does not support him to do this kind of thing.

So the subconscious reaction was to stop Asada Jiro.

Save him from going down a road of no return.

So after regaining his senses, he immediately dissuaded him: "Mr. Asada, the risk of doing this is too great, please forgive me for not obeying."

After all, if any unforeseen accident happened, he himself, as the main research and development personnel of Shenze, would definitely be to blame.

(End of this chapter)